TIAA CREF Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $245K | Buy |
52,971
+1,194
| +2% | +$5.52K | ﹤0.01% | 2846 |
|
2018
Q4 | $181K | Sell |
51,777
-1,186
| -2% | -$4.15K | ﹤0.01% | 2894 |
|
2018
Q3 | $534K | Sell |
52,963
-1,619
| -3% | -$16.3K | ﹤0.01% | 2687 |
|
2018
Q2 | $395K | Sell |
54,582
-1,446
| -3% | -$10.5K | ﹤0.01% | 2871 |
|
2018
Q1 | $338K | Sell |
56,028
-6,452
| -10% | -$38.9K | ﹤0.01% | 2880 |
|
2017
Q4 | $601K | Sell |
62,480
-1,568
| -2% | -$15.1K | ﹤0.01% | 2691 |
|
2017
Q3 | $569K | Hold |
64,048
| – | – | ﹤0.01% | 2774 |
|
2017
Q2 | $810K | Buy |
64,048
+2,250
| +4% | +$28.5K | ﹤0.01% | 2646 |
|
2017
Q1 | $649K | Sell |
61,798
-2,410
| -4% | -$25.3K | ﹤0.01% | 2700 |
|
2016
Q4 | $591K | Sell |
64,208
-5,261
| -8% | -$48.4K | ﹤0.01% | 2784 |
|
2016
Q3 | $819 | Sell |
69,469
-1,985
| -3% | -$23 | ﹤0.01% | 2640 |
|
2016
Q2 | $925K | Sell |
71,454
-40,609
| -36% | -$526K | ﹤0.01% | 2548 |
|
2016
Q1 | $1.79M | Sell |
112,063
-214,997
| -66% | -$3.44M | ﹤0.01% | 2136 |
|
2015
Q4 | $9.36M | Sell |
327,060
-5,908
| -2% | -$169K | 0.01% | 1107 |
|
2015
Q3 | $9.48M | Sell |
332,968
-25,982
| -7% | -$739K | 0.01% | 1078 |
|
2015
Q2 | $12.9M | Sell |
358,950
-102,460
| -22% | -$3.68M | 0.01% | 989 |
|
2015
Q1 | $13.4M | Buy |
461,410
+389,546
| +542% | +$11.3M | 0.01% | 962 |
|
2014
Q4 | $1.52M | Sell |
71,864
-1,900
| -3% | -$40.1K | ﹤0.01% | 2420 |
|
2014
Q3 | $1.43M | Sell |
73,764
-3,238
| -4% | -$62.8K | ﹤0.01% | 2436 |
|
2014
Q2 | $1.2M | Buy |
77,002
+12,904
| +20% | +$201K | ﹤0.01% | 2609 |
|
2014
Q1 | $1.33M | Sell |
64,098
-8,850
| -12% | -$183K | ﹤0.01% | 2476 |
|
2013
Q4 | $941K | Buy |
72,948
+23,430
| +47% | +$302K | ﹤0.01% | 2708 |
|
2013
Q3 | $578K | Buy |
49,518
+5,670
| +13% | +$66.2K | ﹤0.01% | 2893 |
|
2013
Q2 | $202K | Buy |
+43,848
| New | +$202K | ﹤0.01% | 3042 |
|